Aim of this study is to evaluate, in a population of chronic kidney disease patients on dialysis (Stage 5D), the effect of treatment with isonatremic dialysis (vs conventional dialysis), during an observational period of 2 months each, on: * control of interdialytic weight gain * perdialytic tolerance in terms of adverse events occurring during all of the sessions of the study * body composition and thirst measured monthly during the 4 months of follow-up. * tolerance to treatment.
Study Type
OBSERVATIONAL
Enrollment
120
Conventional dialysis treatment
Isonatremic dialysis treatment
Uhmontpellier
Montpellier, France
RECRUITINGChange of interdialytic weight gain during treatment
change of interdialytic weight gain during treatment with isonatremic dialysis vs conventional dialysis during an observational period of 2 months each one.
Time frame: 1, 2, 3 and 4 months after inclusion
Perdialytic tolerance in terms of adverse events occurring
Perdialytic tolerance in terms of adverse events occurring during all sessions of the study with isonatremic dialysis vs conventional dialysis for an observational period of 2 months each one.
Time frame: 1, 2, 3 and 4 months after inclusion
Body composition
Body composition monthly during treatment with isonatremic dialysis vs conventional dialysis during an observational period of 2 months each one.
Time frame: 1, 2, 3 and 4 months after inclusion
Rate of Tolerance
Rate of Tolerance during treatment with isonatremic dialysis vs conventional dialysis during an observational period of 2 months each one.
Time frame: 1, 2, 3 and 4 months after inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.